ORAMED PHARMACEUTICALS INC. (ORMP) › Net IncomeORAMED PHARMACEUTICALS INC. (ORMP) — Net IncomeAnnual figures by fiscal year, from SEC filings.2008: -$2.77M2009: -$2.76M2010: -$2.98M2011: -$1.56M2012: -$3.34M2013: $4.23M2014: -$5.70M2015: -$7.23M2016: -$10.96M2017: -$10.48M2018: -$12.73M2019: -$14.36M2020: -$11.51M2021: -$22.99M2022: -$36.56M2023: $5.09M2024: -$19.06M2025: $64.05M$64.05M2008Net Income (USD)2025Fiscal YearNet IncomeChange YoY2025$64.05M+436.0%2024-$19.06M-474.6%2023$5.09M+113.9%2022-$36.56M-59.0%2021-$22.99M-99.7%2020-$11.51M+19.8%2019-$14.36M-12.8%2018-$12.73M-21.4%2017-$10.48M+4.4%2016-$10.96M-51.6%2015-$7.23M-27.0%2014-$5.70M-234.6%2013$4.23M+226.6%2012-$3.34M-114.2%2011-$1.56M+47.6%2010-$2.98M-7.9%2009-$2.76M+0.3%2008-$2.77M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share